加载中...
2025-05-23
[Global Launch] Mid-Sized Electrochemiluminescence Platform – eCL8600
At the product launch event on May 19, Lifotronic officially unveiled its new eCL8600 ECLIA Analyzer. The launch attracted significant attention and was packed with industry experts and laboratory users. Professor Song Haibo, Vice President of the National Health Industry Enterprise Management Association and President of its Clinical Laboratory Branch, along with Professor Wang Hualiang, Director of the Shanghai Institute of Laboratory Medicine and Chairman of the Laboratory Medicine Branch of the National Health Industry Enterprise Management Association, attended the ceremony and took part in the ribbon-cutting event.
As a continuation of the eCL8000 and eCL9000 product series, the eCL8600 not only inherits the proven consistency and stability of Lifotronic’s ECLIA platform but also delivers major breakthroughs in intelligence and operational convenience:
- Testing speed of up to 200 tests/hour, enabling high-throughput sample processing
- Equipped with 30 reagent positions and 80 sample positions to support multi-analyte parallel testing
- Innovative top-down vision recognition system for precise detection of assay cups and tip quantity
- Real-time display of remaining test capacity for consumables and reagents, with automatic alerts for timely replacement, enhancing lab efficiency and user experience.
The launch of this product marks a key milestone in the series development of Lifotronic’s ECLIA platform, building a complete product matrix for laboratories of all sizes and accelerating automation upgrades for laboratories worldwide.
[Technical Upgrade] High-End HbA1c Flagship Analyzer – H100Plus
On May 20, Lifotronic unveiled the upgraded H100Plus High-Speed HbA1c Analyzer at the exhibition, setting a new technical benchmark for high-end HbA1c testing:
- Ultra-fast 45-second variant detection mode, significantly enhancing efficiency
- Accurate identification of multiple hemoglobin variants including E, D, S, C, and J
- Supports both standalone operation and integrated configurations (HPLC+HPLC / HPLC+CBC), offering flexible solutions for mid- to large-sized laboratories
At the launch event, Professor Massimo Pieri from the Faculty of Medicine and Surgery, University of Rome Tor Vergata, shared his enthusiastic feedback as an end-user:
“H100Plus delivers not only rapid testing but also excellent performance in key metrics such as precision, linearity, and repeatability. Its interference resistance is especially impressive — capable of handling high Schiff base, high carbamylated hemoglobin, varying hematocrit levels, icteric samples, and a wide range of hemoglobin variants (E/D/S/C/J). The results are accurate and reliable, rivaling those of top international brands, and provide a high-quality HbA1c testing solution for clinical laboratories.”
Comprehensive Presence, Empowering the Globe
At this year’s EUROMEDLAB exhibition, Lifotronic not only launched two flagship new products but also showcased its full-scenario IVD solutions across multiple product lines, including immunoassays and clinical chemistry, highlighting its deep market presence and robust global service capabilities.
Looking ahead, Lifotronic will continue to uphold its mission: "Keep developing valuable products and services for human health and lives, and creating value for customers, employees, shareholders, and the society." Through continuous innovation and product excellence, Lifotronic aims to elevate global clinical diagnostics and provide laboratories around the world with more accurate, efficient, and intelligent solutions.
